Ruby J. Anto

Thiruvananthapuram, KL 695317, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Anticancer Potential of Eudesmanolides Derived from Sphagneticola trilobata against Colorectal Cancer, by Targeting β-catenin Signalling.

Anticancer Potential of Eudesmanolides Derived from Sphagneticola trilobata against Colorectal Cancer, by Targeting β-catenin Signalling.

Journal: Anti-cancer agents in medicinal chemistry

Published: August 30, 2025

Uttroside B, a US FDA-designated 'Orphan Drug', mitigates the development of hepatocellular carcinoma and its pulmonary metastasis via EGFR/ERK-mediated inhibition of SREBP-1 and STAT-3.

Uttroside B, a US FDA-designated 'Orphan Drug', mitigates the development of hepatocellular carcinoma and its pulmonary metastasis via EGFR/ERK-mediated inhibition of SREBP-1 and STAT-3.

Journal: Cell death discovery

Published: August 05, 2025

Orphan drug uttroside B impedes MASH progression and HCC development in experimental models.

Orphan drug uttroside B impedes MASH progression and HCC development in experimental models.

Journal: JHEP reports : innovation in hepatology

Published: December 19, 2024

A Novel Combinatorial Regimen Using Sorafenib and Uttroside B, A US FDA-designated 'Orphan Drug', for the Treatment of Hepatocellular Carcinoma.

A Novel Combinatorial Regimen Using Sorafenib and Uttroside B, A US FDA-designated 'Orphan Drug', for the Treatment of Hepatocellular Carcinoma.

Journal: Anti-cancer agents in medicinal chemistry

Published: March 12, 2024

Enhanced extracellular vesicles mediated uttroside B (Utt-B) delivery to Hepatocellular carcinoma cell: Pharmacokinetics based on PBPK modelling.

Enhanced extracellular vesicles mediated uttroside B (Utt-B) delivery to Hepatocellular carcinoma cell: Pharmacokinetics based on PBPK modelling.

Journal: Biochemical and biophysical research communications

Published: January 23, 2024

Editorial: The use of plant metabolites to ameliorate sequelae of chemotherapy.

Editorial: The use of plant metabolites to ameliorate sequelae of chemotherapy.

Journal: Frontiers in pharmacology

Published: October 11, 2023

Corrigendum: Targeting thymidylate synthase enhances the chemosensitivity of triple-negative breast cancer towards 5-FU-based combinatorial therapy.

Corrigendum: Targeting thymidylate synthase enhances the chemosensitivity of triple-negative breast cancer towards 5-FU-based combinatorial therapy.

Journal: Frontiers in oncology

Published: September 26, 2023

Targeting BRF2: insights from in silico screening and molecular dynamic simulations.

Targeting BRF2: insights from in silico screening and molecular dynamic simulations.

Journal: Journal of biomolecular structure & dynamics

Published: September 14, 2023

Editorial: Role of extracellular vesicles (EVs) in pathogenesis, diagnosis, therapeutic delivery, treatment and theranostic applications in cancer.

Editorial: Role of extracellular vesicles (EVs) in pathogenesis, diagnosis, therapeutic delivery, treatment and theranostic applications in cancer.

Journal: Frontiers in bioengineering and biotechnology

Published: September 04, 2023

Phytochemicals as Potential Lead Molecules against Hepatocellular Carcinoma.

Phytochemicals as Potential Lead Molecules against Hepatocellular Carcinoma.

Journal: Current medicinal chemistry

Published: August 03, 2023

Editorial: Curcuminoids: their pleiotropism against hallmarks of cancers.

Editorial: Curcuminoids: their pleiotropism against hallmarks of cancers.

Journal: Frontiers in pharmacology

Published: July 25, 2023

Targeting receptor tyrosine kinase signaling: Avenues in the management of cutaneous squamous cell carcinoma.

Targeting receptor tyrosine kinase signaling: Avenues in the management of cutaneous squamous cell carcinoma.

Journal: iScience

Published: May 26, 2023

Showing 1-12 of 51

Last Updated: 09/26/2026